tokens: The purpose of this article is to discuss the factors involved in the selection of antibodies , radionuclides and labeling methods in the development of radioimmunotherapy ( RIT ) for non - Hodgkin ' s lymphoma ( NHL ) from a single clinical study site through multicenter trials and commercialization .